Urokinase Injection is a potent thrombolytic agent used to break down harmful blood clots in the circulatory system. It dissolves fibrin—the primary component of blood clots. Clinically indicated in the treatment of acute pulmonary embolism, deep vein thrombosis, and post-surgical clot complications, Urokinase plays a crucial role in re-establishing normal blood circulation and reducing the risk of serious vascular events. The formulation is administered under medical supervision in controlled settings such as hospitals and emergency care units.
Dosage and administration should be determined by a healthcare professional
The most common uses of Urokinase Injection include:
Explore our diverse range of pharmaceutical manufacturing categories, designed to deliver high-quality, reliable, and innovative healthcare solutions across multiple dosage forms.
Corporate Office
Plot No. :46 First Floor, Industrial Area Phase-2, Chandigarh-160002, India.
Manufacturing Unit
Village Kondi, Post Thana, District Solan, Baddi 173205 Himachal Pradesh, India.
